Cargando…

Non-antigenic and antigenic interventions in type 1 diabetes

Type 1 diabetes (T1D) results from autoimmune destruction of the pancreatic β-cells. Current T1D therapies are exclusively focused on regulating glycemia rather than the underlying immune response. A handful of trials have sought to alter the clinical course of T1D using various broad immune-suppres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rydén, Anna KE, Wesley, Johnna D, Coppieters, Ken T, Von Herrath, Matthias G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4896560/ https://www.ncbi.nlm.nih.gov/pubmed/24165565 http://dx.doi.org/10.4161/hv.26890

Ejemplares similares

Metabolic syndrome – Removing roadblocks to therapy: Antigenic immunotherapies()
por: Coppieters, Ken T., et al.
Publicado: (2014)

The Development of Immunotherapy Strategies for the Treatment of Type 1 Diabetes
por: Coppieters, Ken, et al.
Publicado: (2018)

The Type 1 Diabetes Signature: Hardwired to Trigger Inflammation?
por: Coppieters, Ken T., et al.
Publicado: (2014)

Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential
por: Peakman, Mark, et al.
Publicado: (2010)

Overcoming Obstacles in the Development of Antigen-Specific Immunotherapies for Type 1 Diabetes
por: Thomas, Ranjeny, et al.
Publicado: (2021)

Antigen-Specific Regulatory T Cells and Low Dose of IL-2 in Treatment of Type 1 Diabetes
por: Pham, Minh N., et al.
Publicado: (2016)

The healthy exocrine pancreas contains preproinsulin-specific CD8 T cells that attack islets in type 1 diabetes
por: Bender, Christine, et al.
Publicado: (2020)

Peripheral autoreactive CD8 T‐cell frequencies are too variable to be a reliable predictor of disease progression of human type 1 diabetes
por: Wesley, Johnna D, et al.
Publicado: (2021)

Low HLA binding of diabetes-associated CD8+ T-cell epitopes is increased by post translational modifications
por: Sidney, John, et al.
Publicado: (2018)

Can We Learn From Viruses How to Prevent Type 1 Diabetes?: The Role of Viral Infections in the Pathogenesis of Type 1 Diabetes and the Development of Novel Combination Therapies
por: von Herrath, Matthias
Publicado: (2009)

A Novel Technique for the In Vivo Imaging of Autoimmune Diabetes Development in the Pancreas by Two-Photon Microscopy
por: Coppieters, Ken, et al.
Publicado: (2010)

Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients
por: Coppieters, Ken T., et al.
Publicado: (2012)

Systematic Assessment of Immune Marker Variation in Type 1 Diabetes: A Prospective Longitudinal Study
por: Speake, Cate, et al.
Publicado: (2019)

Viral Trigger for Type 1 Diabetes: Pros and Cons
por: Filippi, Christophe M., et al.
Publicado: (2008)

Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes
por: Richardson, Sarah J., et al.
Publicado: (2016)

Potential viral pathogenic mechanism in human type 1 diabetes
por: Schneider, Darius A., et al.
Publicado: (2014)

Recent advances in understanding Type 1 Diabetes
por: Christoffersson, Gustaf, et al.
Publicado: (2016)

Blockade but Not Overexpression of the Junctional Adhesion Molecule C Influences Virus-Induced Type 1 Diabetes in Mice
por: Christen, Selina, et al.
Publicado: (2013)

A Deeper Look into Type 1 Diabetes – Imaging Immune Responses during Onset of Disease
por: Christoffersson, Gustaf, et al.
Publicado: (2016)

Immunotherapy for the Prevention and Treatment of Type 1 Diabetes: Optimizing the path from bench to bedside
por: Bresson, Damien, et al.
Publicado: (2009)

Cure of Chronic Viral Infection and Virus-Induced Type 1 Diabetes by Neutralizing Antibodies
por: Ejrnaes, Mette, et al.
Publicado: (2006)

Cure of Chronic Viral Infection and Virus-Induced Type 1 Diabetes by Neutralizing Antibodies
por: Ejrnaes, Mette, et al.
Publicado: (2006)

New Insights Into the Role of Autoreactive CD8 T Cells and Cytokines in Human Type 1 Diabetes
por: Bender, Christine, et al.
Publicado: (2021)

Current and future therapies for type 1 diabetes
por: von Scholten, Bernt Johan, et al.
Publicado: (2021)

Functional Redundancy of CXCR3/CXCL10 Signaling in the Recruitment of Diabetogenic Cytotoxic T Lymphocytes to Pancreatic Islets in a Virally Induced Autoimmune Diabetes Model
por: Coppieters, Ken T., et al.
Publicado: (2013)

BDC12-4.1 T-Cell Receptor Transgenic Insulin-Specific CD4 T Cells Are Resistant to In Vitro Differentiation into Functional Foxp3(+) T Regulatory Cells
por: Sarikonda, Ghanashyam, et al.
Publicado: (2014)

Response to Comment on Rodriguez-Calvo et al. Increase in Pancreatic Proinsulin and Preservation of β-Cell Mass in Autoantibody-Positive Donors Prior to Type 1 Diabetes Onset. Diabetes 2017;66:1334–1345
por: Rodriguez-Calvo, Teresa, et al.
Publicado: (2017)

T-bet Controls Autoaggressive CD8 Lymphocyte Responses in Type 1 Diabetes
por: Juedes, Amy E., et al.
Publicado: (2004)

Means, Motive, and Opportunity: Do Non-Islet-Reactive Infiltrating T Cells Contribute to Autoimmunity in Type 1 Diabetes?
por: Rodriguez-Calvo, Teresa, et al.
Publicado: (2021)

Antigen-specific immunotherapy to restore antigen-specific tolerance in Type 1 diabetes and Graves’ disease
por: Zala, Aakansha, et al.
Publicado: (2022)

Antigen-Based Therapy for the Treatment of Type 1 Diabetes
por: Tian, Jide, et al.
Publicado: (2009)

Increased Immune Cell Infiltration of the Exocrine Pancreas: A Possible Contribution to the Pathogenesis of Type 1 Diabetes
por: Rodriguez-Calvo, Teresa, et al.
Publicado: (2014)

Erratum. Increased Immune Cell Infiltration of the Exocrine Pancreas: A Possible Contribution to the Pathogenesis of Type 1 Diabetes. Diabetes 2014;63:3880–3890
por: Rodriguez-Calvo, Teresa, et al.
Publicado: (2016)

Altered Function of Antigen-Presenting Cells in Type 1 Diabetes: A Challenge for Antigen-Specific Immunotherapy?
por: Creusot, Rémi J., et al.
Publicado: (2018)

Self-Antigens Targeted by Regulatory T Cells in Type 1 Diabetes
por: Mitchell, Angela M., et al.
Publicado: (2022)

Beta cell antigens in type 1 diabetes: triggers in pathogenesis and therapeutic targets
por: Moser, Anna, et al.
Publicado: (2010)

Engineered RBCs Encapsulating Antigen Induce Multi-Modal Antigen-Specific Tolerance and Protect Against Type 1 Diabetes
por: Raposo, Colin J., et al.
Publicado: (2022)

Increased Memory Conversion of Naïve CD8 T Cells Activated during Late Phases of Acute Virus Infection Due to Decreased Cumulative Antigen Exposure
por: Fousteri, Georgia, et al.
Publicado: (2011)

Discriminating antigen and non-antigen using proteome dissimilarity: bacterial antigens
por: Ramakrishnan, Kamna, et al.
Publicado: (2010)

Interference with pancreatic sympathetic signaling halts the onset of diabetes in mice
por: Christoffersson, Gustaf, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_23mh1r26djl030fhofvm6n59j7